Dietary Pantothenic Acid (Vitamin B5)

Overview

Pantothenic acid (vitamin B5) derives its name from the Greek word "pantos" meaning "everywhere," reflecting its ubiquitous presence in foods. This water-soluble vitamin is an essential precursor for the synthesis of coenzyme A (CoA), one of the most important cofactors in metabolism. CoA participates in over 100 different metabolic reactions, including energy production from macronutrients, fatty acid synthesis and oxidation, cholesterol synthesis, and the synthesis of steroid hormones, neurotransmitters, and heme. Pantothenic acid is also a component of acyl carrier protein (ACP), essential for fatty acid synthesis.

Biological Functions

• Coenzyme A synthesis: Pantothenic acid is converted to CoA through a five-step pathway
• Acetyl-CoA formation: Central metabolite in the citric acid cycle; substrate for fatty acid and cholesterol synthesis
• Fatty acid metabolism: CoA required for both beta-oxidation and fatty acid synthesis
• Citric acid cycle: Multiple CoA-dependent reactions (citrate synthase, alpha-ketoglutarate dehydrogenase, succinyl-CoA synthetase)
• Acyl carrier protein (ACP): 4'-phosphopantetheine (from pantothenic acid) is the prosthetic group of ACP in fatty acid synthase
• Steroid hormone synthesis: CoA required for cholesterol-derived hormone production
• Neurotransmitter synthesis: Acetyl-CoA is precursor for acetylcholine
• Protein acetylation: Acetyl-CoA donates acetyl groups for histone and protein modification

Health Significance

Due to its widespread availability in foods, pantothenic acid deficiency is extremely rare in humans consuming a varied diet. The vitamin's role in CoA synthesis makes it theoretically important for numerous metabolic processes, but clinical conditions specifically attributed to deficiency are uncommon. Pantothenic acid derivatives (pantothenol, pantethine) have been investigated for wound healing and lipid-lowering effects, respectively, though evidence remains limited.

Clinical Interpretation Guidelines

• Adequate Intake (AI): Only AI values exist (no RDA) due to limited data
• Daily monitoring: Compare cumulative intake against AI values
• Trend analysis: Assess 7-14 day averages for consistent adequacy
• Dietary assessment: Low pantothenic acid often indicates overall poor diet quality
• Laboratory markers: Whole blood or erythrocyte pantothenic acid can be measured but rarely needed clinically
• Urinary excretion: Reflects recent intake; <1 mg/day suggests deficiency

Deficiency

Natural deficiency is exceptionally rare due to the vitamin's widespread distribution in foods. Most knowledge comes from experimental deficiency studies using pantothenic acid antagonists (omega-methylpantothenic acid) or highly restricted diets.

Experimentally-induced deficiency symptoms:

• Neurological: Numbness and burning sensation in feet ("burning feet syndrome"), paresthesias, impaired coordination
• Gastrointestinal: Nausea, vomiting, abdominal cramps
• General: Fatigue, malaise, headache, sleep disturbances, irritability
• Metabolic: Impaired glucose tolerance, increased insulin sensitivity
• Immune: Impaired antibody production

Historical context: "Burning feet syndrome" was observed in malnourished prisoners of war in World War II and responded to pantothenic acid supplementation, though it may have been part of broader malnutrition.

At-risk populations:

• Severe malnutrition (rare in developed countries)
• Chronic alcoholism (often combined with other B-vitamin deficiencies)
• Pantothenate kinase-associated neurodegeneration (PKAN) - rare genetic disorder

Toxicity/Excess

No Tolerable Upper Intake Level (UL) has been established for pantothenic acid. The vitamin is considered to have low toxicity, with no consistent adverse effects reported even at high supplemental doses.

High-dose observations (typically 10-20 g/day):

• Diarrhea and gastrointestinal disturbances are the most commonly reported effects
• Nausea at very high doses
• No serious toxicity documented

Pantethine (dimeric form of pantetheine, a CoA precursor):

• Used at doses of 900-1200 mg/day for lipid modification
• Generally well-tolerated
• GI side effects possible

Food Sources

• Excellent sources (>2 mg/serving): Beef liver, chicken liver, sunflower seeds, shiitake mushrooms, fortified cereals
• Good sources (1-2 mg/serving): Avocado, chicken breast, beef, salmon, lobster, egg yolk, sweet potato
• Moderate sources (<1 mg/serving): Milk, yogurt, broccoli, potatoes, whole grains, legumes, tomatoes, strawberries

Note: The name "pantothenic" reflects its presence in virtually all foods. Processing, canning, and refining can reduce content by 20-80%. Whole, unprocessed foods are the best sources.

Special Populations

• Pregnancy and lactation: Modestly increased requirements (6-7 mg/day AI)
• Chronic alcohol users: Often have multiple B-vitamin deficiencies including potentially pantothenic acid
• Highly processed diet consumers: May have lower intake due to processing losses
• Athletes: Theoretical increased requirements with high energy expenditure, though not well-established
• Diabetics: Some research on pantothenic acid derivatives for wound healing
• Patients with pantothenate kinase-associated neurodegeneration (PKAN): Rare genetic disorder; high-dose pantothenic acid not effective; other treatments used
• Patients taking lipid-lowering supplements: Pantethine has modest lipid effects

Drug Interactions

Pantothenic acid has remarkably few documented drug interactions, likely due to its wide availability and established safety.

• Cholinesterase inhibitors (donepezil, rivastigmine): Theoretical interaction as pantothenic acid is required for acetyl-CoA (acetylcholine precursor); clinical significance unknown
• Biotin (high doses): May compete for intestinal absorption
• Dapsone: May have some interaction with pantothenic acid metabolism
• Oral contraceptives: May slightly affect pantothenic acid status (limited data)

Note: Unlike many other nutrients, pantothenic acid is not known to have significant interactions with common medications.

Caveats & Limitations

• Adequate Intake only: No RDA established; AI based on estimated intake data
• Self-reported intake: Accuracy depends on user diligence and food database quality
• Processing losses: Food database values may not reflect actual content after cooking
• Bioavailability: Generally high (40-60%) but varies by food source
• No direct measurement: HealthKit data reflects intake estimates, not blood levels
• Deficiency rare: Clinical relevance of tracking is limited in well-nourished populations
• Limited clinical applications: Few specific conditions where pantothenic acid supplementation is indicated
• Combined deficiencies: In malnutrition, deficiency occurs with multiple B-vitamins
• Pantethine distinct: Lipid-lowering effects of pantethine do not apply to pantothenic acid